Landmark Study of Variant Reclassifications Published
A study of variant reclassification results shows that 25% of all reported variants of uncertain significance were reclassified over a 10-year period.
Read MorePosted by Steve Halasey | Nov 6, 2018 | Research |
A study of variant reclassification results shows that 25% of all reported variants of uncertain significance were reclassified over a 10-year period.
Read MorePosted by Steve Halasey | Nov 6, 2018 | Research |
The test supports international guidelines for treating antibiotic-resistant STIs.
Read MorePosted by Steve Halasey | Nov 6, 2018 | Standards |
The cell line-derived myeloid cancer reference standard contains 22 mutations across 19 oncology-relevant genes.
Read MorePosted by Melissa Mayer | Oct 28, 2018 | Allergy & Autoimmune, Culture Media, Respiratory Disease |
The test uses genetic biomarkers to determine with high accuracy whether inhaled substances and chemicals that come into contact with the lungs are allergenic or not.
Read MorePosted by Melissa Mayer | Oct 26, 2018 | Infectious Diseases, Molecular Diagnostics, Point-of-Care |
Enables hepatitis C point-of-care molecular testing and linkage to care.
Read More